Abstract: The Fabry-Perot modulator, consisting of Fabry-Perot etalon plates separated by an electrooptic material such as KDP, is analyzed in detail. Time-dependent perturbation theory is used to ...
Amicus Therapeutics’ first oral drug for the rare condition Fabry disease has been approved by the FDA, giving patients an alternative to conventional injected enzyme replacement therapy.